Stock movement in Hong Kong | Syno Pharmaceutical-B (02257.HK) rose more than 17% during midday trading. The net loss attributable to shareholders for the first half of the year narrowed by 91% year-on-year. STP705 is expected to complete commercialization within the year.
According to the Smart Financial News APP, Sinopharm-B (02257.HK) rose more than 17% during the trading day, with an increase of 15.84% as of the time of writing, reaching 11.85 Hong Kong dollars, with a trading volume of 1504.43 million Hong Kong dollars.
Latest
2 m ago
